Skip to main content

Δ-8-Tetrahydrocannabinol Facts

Cannabinoid; Cannabinoid; Cannabinoid CB1 receptor partial agonist

Description

Δ8-THC (delta-8-tetrahydrocannabinol) — "diet weed," "legal THC" — is a synthetic cannabinoid of the terpenophenolic class. It activates cannabinoid receptors in the brain, producing a milder version of the cannabis high.[1]

Subjective effects include relaxation, mild euphoria, appetite stimulation, reduced anxiety, and time dilation. The experience is a clearer-headed, less anxious version of the cannabis high — the same general character as Δ9-THC but with a wider comfortable dose window.[2]

Δ8-THC produces physical dependence through receptor desensitization, but no lethal dose has been established in any species.[3] The dominant real-world risk is product contamination — commercial Δ8-THC is synthesized from hemp CBD and routinely contains unidentified byproducts far exceeding labeled levels.[4]

Dose and durationby route · individual sensitivity varies

Oral(mg)
Threshold< 5 mgLight5 – 15 mgCommon15 – 40 mgStrong40 – 80 mgHeavy80+ mg

Starts in 30 – 120 minLasts 4 – 8 hoursAfter-effects 2 – 12 hours

Body and dependence

Acute toxicity
Low
Chronic toxicity
Low
Physical dependence
Low
Psychological dependence
Moderate
Withdrawal
Mild
Compulsive redosing
Low

Tolerance

Builds
Moderate
Fully resets after
21 days
Carries over to
Δ9-THC; WIN 55,212-2; Synthetic cannabinoids (CB1 agonists)

Effectslikely at a common dose

Perception
none likely · 15 possible, including Spatial disorientation, Vestibular distortion
Body
Body high; Dry mouth; +16 possible, including Heart rate perception changes, Motor control impairment, Abnormal heartbeat
Thinking
none likely · 31 possible, including Cognitive impairment, Memory suppression, Decision impairment
Feeling
Euphoria; +5 possible, including Anxiety, Emotional lability, Paranoia
Self
none likely · 10 possible, including Craving, Depersonalization, Derealization
Time
Time alteration; +1 possible

Who shouldn't take it

Absolute
History of psychotic disorders; Pregnancy and lactation; Pediatric populations
Relative
Cardiovascular disease; Hepatic impairment; Anticoagulant therapy (warfarin)

Combinations60 recorded

Dangerous (11)
Ketamine, DXM, PCP; Opioids; GHB, Baclofen; GHB, GBL; Ibogaine; Local anesthetics; MAOIs; NDRIs (Wellbutrin); Salvia, Ibogaine; SNRIs; Synthetic cannabinoids
Caution (34)
See full page: psychedex.org/substances/delta-8-thc
Not graded (15)
Not listed never means safe.

Seek help immediately if

Natural cannabis rarely causes a medical emergency — "greening out" is: pale/sweaty skin, dizziness, nausea or vomiting, anxiety or panic, rapid heartbeat, feeling faint — and usually passes with rest.

Seek emergency help for these — far more likely with synthetic cannabinoids ("spice" / K2):

  • Seizures
  • Severe chest pain; very fast or irregular heartbeat
  • Unresponsiveness or extreme drowsiness
  • Severe agitation, aggression, or psychosis
  • Repeated vomiting; difficulty breathing

What to do

  1. Sit or lie them down somewhere calm, cool, and quiet
  2. Reassure them — cannabis panic and "greening out" pass with time
  3. Offer sips of water; a little sugar can help if they feel faint
  4. Recovery position if nauseated, drowsy, or vomiting
  5. Stay with them and monitor
  6. For seizures, chest pain, unresponsiveness, or severe agitation, call emergency services

Natural cannabis "greening out" resolves with rest, calm, and time, with no lasting harm. Synthetic cannabinoids are unpredictable and can cause seizures, cardiac events, kidney injury, and severe agitation that needs emergency care.

988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE

Version r1.a1 · Not medical advice

References

  1. [1]
    ^Tagen M, Klumpers LE (2022) Review of delta-8-tetrahydrocannabinol (Δ8-THC): Comparative pharmacology with Δ9-THC — British Journal of Pharmacology doi:10.1111/bph.15865
  2. [2]
    ^Kruger JS, Kruger DJ (2022) Delta-8-THC: Delta-9-THC's nicer younger sibling? — Journal of Cannabis Research doi:10.1186/s42238-021-00115-8
  3. [3]
    ^Vanegas SO, Reck AM, Rodriguez CE, Marusich JA, Yassin O, Sotzing G, Wiley JL, Kinsey SG (2022) Assessment of dependence potential and abuse liability of Δ8-tetrahydrocannabinol in mice — Drug and Alcohol Dependence doi:10.1016/j.drugalcdep.2022.109640
  4. [4]
    ^Ray CL, Bylo MP, Pescaglia J, Gawenis JA, Greenlief CM (2022) Delta-8 Tetrahydrocannabinol Product Impurities — Molecules doi:10.3390/molecules27206924
Print version
Report an issue